GL1X · GenesisL1 explorer

Research workbench

Xfel crystal structure of the prostaglandin D2 receptor CRTH2 in complex with 15R-methyl-PGD2

Analyse Xfel crystal structure of the prostaglandin D2 receptor CRTH2 in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7M8W
Type
protein
Length
437 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Prostaglandin D2 receptor 2, endolysin chimera
UniProt
Q9Y5Y4, D9IEF7
Ligands
YSS, NA, SO4
Pockets
4 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 73% helix, 2% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProstaglandin D2 receptor 2, endolysin chimeraprotein43773% helix, 2% strandQ9Y5Y4, D9IEF7

Ligands and binding sites

  • YSS · 15R-methyl-prostaglandin D2 · ligand · chains A
  • NA · Sodium ion · metal · chains A
  • SO4 · Sulfate ion · ion · 5 copies · chains A
  • FLC · Citrate anion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14370.780.8641YSS
25740.680.7840FLC, SO4
31170.500.8020empty
41320.440.7623empty

Modifications

Observed in the structure: 2 disulfide, 1 modified (disulfide, alkylation).

Compared structures

  • 7M8W · XFEL crystal structure of the prostaglandin D2 receptor CRTH2 in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9Y5Y4 · AlphaFold monomer V2.0 prediction for prostaglandin D2 receptor 2 (Q9Y5Y4) · a predicted model of the same protein · chain A against A, TM-score 0.72

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.